INTRODUCTION {#S1}
============

T-cell development occurs in the thymus and depends on a diverse array of functionally distinct epithelial cell types within the thymic stroma. These thymic epithelial cell (TEC) types originate from the endoderm of the third (and in some species fourth) pharyngeal pouches (PPs), transient bilateral endodermal structures that generate both the thymus and parathyroid glands ([@R40]; [@R24]). The molecular and cellular processes that govern thymus organogenesis are best understood in the mouse ([@R8]; [@R48]). By contrast, knowledge of human thymic organogenesis is based primarily on histological studies, with molecular insight currently limited to analysis of genetic abnormalities affecting thymus development; principally, DiGeorge Syndrome, the human *nude* syndrome and APECED, which are caused by mutations in *TBX1, FOXN1* and *AIRE*, respectively ([@R20]; [@R5]; [@R70]).

The human thymus is thought to develop from either the third PP ([@R56]) or from both the third and fourth PP ([@R69]). As in the mouse, the bilateral human primordia initially each comprise thymic and parathyroid domains, and are encased in a neural crest-derived mesenchymal capsule from early in development. From week 7 \[Carnegie stage (CS) 18-19\] to mid-week 8 (CS20-21) of gestation the thymic component of this primordium migrates ventrally, such that the leading tip of the migrating thymic rudiment remains attached to the parathyroid by a thin, elongated, highly lobulated, cord-like structure. This structure then resolves, separating the parathyroid and thymic primordia ([@R56]), and the two thymic primordia meet and attach at the pericardium by mid-week 8 ([@R56]). It is well documented that an accessory thymus can exist in the cervical region in humans ([@R56]; [@R69]) and, similarly, the occurrence of cervical thymi in the mouse has recently been reported ([@R14]; [@R67]).

The early human thymic primordium is proposed to contain undifferentiated epithelial cells, as reported for the mouse ([@R39]; [@R7]; [@R62]). Medullary development has been observed from week 8 and distinct cortical and medullary compartments by week 16. The presence of other intrathymic cell types, including mesenchymal, vascular and lymphoid cells, has been reported from mid-week 8 ([@R30]; [@R29]). Between 14 and 16 weeks, mature lymphocytes begin to leave the thymus to seed the peripheral immune system ([@R69]; [@R44]). However, although the morphological events in human thymus organogenesis are well documented and some information exists regarding TEC differentiation, molecular regulation of these processes remains poorly understood. In particular, only very limited information exists regarding the extent to which mechanisms known to govern thymus development and function in the mouse are conserved in human. Furthermore, neither the time of onset of TEC differentiation nor the identity of markers defining thymic epithelial progenitor cells (TEPCs) has been determined in the human fetal thymus. Similarly, neither the timing of initial hematopoietic colonization nor the identity of the colonizing cells has been reported. Improved understanding is urgently required, owing to the clinical need for improved strategies for enhancing or replacing thymus function in patients ([@R72]; [@R45]; [@R3]).

Here, we demonstrate that the major mechanisms currently known to underpin thymus organogenesis are conserved between mouse and human. We further define the age at which overt TEC differentiation is initiated in human fetal thymus, and establish the timing of expression of known mediators of TEC function, including the autoimmune regulator AIRE and the chemokines CCL21 and CCL25. These observations delineate the stage in thymus development at which the thymus is composed principally of undifferentiated thymic epithelial progenitor cells. Finally, we determine the stage of thymus organogenesis at which colonization by hematopoietic, endothelial and mesenchymal cells first occurs, identifying the first colonizing hematopoietic cells as CD45^+^CD7^-^CD34^lo/-^ and the first thymus-seeding T-lineage progenitors as CD45^+^CD7^+^CD34^int^ cells, in contrast to expectations from previous studies ([@R27]). These data, to our knowledge, constitute the first detailed analysis of human thymus organogenesis and TEC development that is not based solely on morphological and histological data, and thus provide essential information for the translation of principles established in the mouse to the human.

MATERIALS AND METHODS {#S2}
=====================

Human tissue {#S3}
------------

First and second trimester human fetuses were obtained following elective medical termination of pregnancy, and all were morphologically normal. Ethical approval for use of human fetal tissue in these studies was granted by the Lothian Research Ethics Committee or the Ethics Committee of the Erasmus University Medical Center. Consent was obtained from all women in writing, and the tissue was anonymized before being made available for research. All experiments using human tissue were performed at the University of Edinburgh or the Erasmus University Medical Center. Embryos were aged according to the standard head/rump measurement and Carnegie stage was determined ([@R22]; [@R58]). Embryos used in this study were from mid- to late week 6 (CS17), week 7 (CS18-19), early to mid-week 8 (CS20-21), and weeks 9, 10, 15-16 and 17, with days/weeks indicating days/weeks post-fertilization. Note that Carnegie staging does not apply to second trimester fetuses.

*In situ* hybridization {#S4}
-----------------------

Whole-mount *in situ* hybridizations were performed as previously described ([@R23]). Probes were made by PCR amplification from human fetal tissue using primers as listed in [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.087320/-/DC1) Table S1.

Immunohistochemistry {#S5}
--------------------

Immunohistochemistry was performed as previously described ([@R24]). Primary antibodies used were: anti-cytokeratin (rabbit polyclonal anti-keratin, Dako); anti-CLDN4 (3E2C1, Zymed); anti-human CD45 (clone HI30, BD Pharmingen); anti-keratin 5 (AF138 rabbit IgG, Covance); anti-keratin 8 (CAM 5.2, Becton Dickinson); anti-keratin 14 (AF64, Covance); TE7 (Developmental Studies Hybridoma Bank); UEA1 (biotinylated, Vector Labs); anti-AIRE (D-17, Santa Cruz); anti-CD205 (MG38, Serotec); CDR2 (provided by B. Kyewski, German Cancer Research Center, Heidelberg, Germany); anti-HLA-DR/DP/DQ (clone TU39, BD Pharmingen); anti-EPCAM (Ber-EP4, DakoCytomation); anti-CCL21 (anti-6Ckine, R&D Systems); anti-CCL25/TECK (R&D Systems); mouse anti-CD11b/Mac1 (ICRF44, BD Pharmingen); mouse anti-CD31 (WM59, BD Pharmingen); mouse anti-CD144 PE (16B1, eBiosciences); mouse anti-CD34 FITC (581, BD Pharmingen); mouse anti-CD7 (M-T701, BD Pharmingen). Unconjugated antibodies were detected using goat anti-mouse Alexa488, goat anti-rabbit Alexa647, goat anti-rat Alexa488, chicken anti-goat Alexa488, chicken anti-rabbit Alexa594, donkey anti-goat IgG Alexa488, streptavidin-Alexa647 (all Invitrogen). Appropriate isotype-control antibodies (BD Pharmingen) provided negative controls in all experiments. DAPI was used as a nuclear counterstain.

Microscopy {#S6}
----------

Thymic tissue was microdissected from embryos using an Olympus SZH dissecting microscope. Images were captured using a ZEISS Stemi SVII stereomicroscope, an Olympus BX61 stereomicroscope, a Leica AOBS confocal microscope or a Leica DMRXA microscope under the appropriate excitation conditions, and were processed using Adobe Photoshop CS4.

Flow cytometry {#S7}
--------------

Thymic single cell suspensions were generated by using enzymatic dissociation as described for mouse fetal thymus ([@R57]) or by mincing thymic fragments through a 100-μm filter (BD). Flow cytometric analysis was performed on a LSRII Flow Cytometer (BD) and analyzed using FlowJo software (Tree Star). Antibodies used were: mouse anti-CD19 DY590 (Exbio Praha), mouse anti-BDCA2 APC (Miltenyi Biotech), rat anti-CD7 (MCA344, Serotec), mouse anti-human CD45 (clone HI30), mouse anti-human CD34 FITC (clone 581), mouse anti-CD3 Alexa700, mouse anti-CD45 PerCP-Cy5, mouse anti-HLA-DR APC-Cy7, mouse anti-CD123 PE (all BD Pharmingen). Unconjugated antibodies were detected with goat anti-mouse Alexa647 and goat anti-mouse Alexa 568 (Invitrogen).

Grafted re-aggregate fetal thymic organ culture {#S8}
-----------------------------------------------

Two human thymic lobes (early week 8) were lightly dissociated as described, mixed with 150,000 mouse primary embryonic fibroblasts and re-aggregated as described previously ([@R66]). The re-aggregates were cultured on a filter for 24 hours and then grafted under the kidney capsule of NOD/SCID recipient mice the next morning. Grafts were recovered after 2 weeks for analysis.

Affymetrix microarray analysis {#S9}
------------------------------

RNA was prepared from three independent mid-week 8 thymic lobes microdissected free of any other cells or tissues (CB094, CS20; CB388, CS21/22; CB106, CS22). Note that the name of each sample includes both an identifier (e.g. CB094) and the Carnegie stage of that sample (e.g. CS20). Samples were amplified, labeled and hybridized to Affymetrix Human Genome U133Plus2 GeneChip arrays according to standard Affymetrix protocols. The microarray data were normalized independently using RMA ([@R33]) and Micro Analysis Suite 5.0 (MAS5) ([@R41]), and the probe sets were then ranked based on the resulting expression values, with the probe set having the highest expression given rank-1. The data are deposited in the Stem Cell Database under accession number StemDB-2316 (<http://www.stemdb.org/stemdb/utils/show?id=StemDB-2316>). The data presented show ranks for selected probe sets along with the corresponding MAS5 PMA flag \[present (P), marginal (M) and absent (A)\]. For a given probe set, the lower the rank the higher the probability of the gene being present in the sample, whereas MAS5 predicts the presence or absence of a gene using different statistics. Data were analyzed using Limma and Affymetrix Bioconductor packages and visualized using Genespring GX (Agilent).

RESULTS {#S10}
=======

Spatial and temporal expression of essential regulators of mouse thymus organogenesis is conserved in human thymus development {#S11}
------------------------------------------------------------------------------------------------------------------------------

To determine whether molecular mechanisms that regulate thymus development are conserved between mouse and human, we investigated the detailed spatial and temporal expression profiles of known regulators of mouse thymus organogenesis in human embryos. We first confirmed the relative staging of human and mouse thymus development. The earliest human tissue available for this study was early week 6 (CS16). At this stage, the third PP had formed and morphological criteria indicated that third PP/thymic primordium development was at an equivalent stage to that at embryonic day (E)10.5 in CBAxC57BL/6 F1 mouse embryos. By early week 7 (CS18), outgrowth of the third PP to form the common thymus/parathyroid primordium ([@R23]) had occurred, equivalent to ∼E11.5 in the mouse ([Fig. 1A](#F1){ref-type="fig"}). Migration of the thymus component of the primordium along the carotid artery was observed by mid-week 8 (CS21), as described, and at this and subsequent stages the thymic primordium was surrounded by a mesenchymal capsule ([Fig. 1B-B″](#F1){ref-type="fig"}). By week 10, the thymic primordium comprised numerous lobules ([Fig. 1C,C′](#F1){ref-type="fig"}; note that the mid-week 8 thymus is not lobulated), and lobules could also be seen within the elongated cord connecting the thymus and parathyroid primordia ([Fig. 1C,C′](#F1){ref-type="fig"}). Of note is that from week 8, the mesenchyme surrounding the human thymic primordium was less closely associated with the primordium than is the mesenchymal capsule in the mouse ([Fig. 1C](#F1){ref-type="fig"}, arrow).

![**Morphological features of early human thymus development.** (**A-C**′) Images show microdissected human fetal thymic primordia at the ages shown, except for B, which shows anatomical details of the exposed chest cavity to indicate relative locations of thymic primordia, carotid artery and heart. B″ shows detail from lower part of thymic primordium (i.e. the leading edge during migration). Arrowheads indicate thymic primordial; white arrow in C indicates mesenchymal capsule. Images are representative of at least two independent analyses. H, heart; Th, thymus; Wk, week.](DEV087320F1){#F1}

We then investigated the expression pattern in week 6 human embryos of *TBX1, HOXA3, PAX1* and *PAX9* genes, which encode proteins with genetically defined roles in patterning of the pharyngeal endoderm (PE) and/or formation of the third PP. *Tbx1* is required for development of the mouse foregut endoderm, where it regulates segmentation of the PE and PP patterning ([@R73]). Conserved stage-specificity and localization of *TBX1* expression between mouse and human embryos was demonstrated (ISH; [Fig. 2A,A′](#F2){ref-type="fig"}). In the early week 6 (CS16) human embryo, *TBX1* expression was detected in the core mesenchyme of the first, second and third pharyngeal arches (PAs) and in the third PP endoderm ([Fig. 2A,A′](#F2){ref-type="fig"}). Expression was also detected in the epithelium of the caudal half of the otic vesicle ([Fig. 2A](#F2){ref-type="fig"}).

![**Expression profile of known regulators of mouse thymus organogenesis in human thymus development.** Images show whole or sectioned human embryos or microdissected thymic primordia after *in situ* hybridization with the probes indicated. Ages of embryos or dissected thymus lobes are as shown. (**A-D**′) *TBX1, HOXA3* and *PAX1* images show side view of whole embryos (top) and coronal sections (bottom). *PAX9* images show side view of whole embryo; lower panel shows detail of upper panel. (**E**,**E**′) *FOXN1* images showing ventral view of whole embryos. (**F-F**″) *P63* images showing side view of whole embryos (left and middle) and dissected thymic lobe. (**G-H**) *BMP4* and *BMP2* images showing side view of whole embryos. (**I**) *CLDN4* image showing dissected thymic lobe. Images are representative of at least two independent analyses. PP1, first PP; PP2, second PP; PP3, third PP; PP4, fourth PP; Th, thymus; Wk, week.](DEV087320F2){#F2}

*Hoxa3* is expressed in the mouse from E9.5 in the third pharyngeal cleft ectoderm, in the third and fourth PA neural crest cells, and in the third PP endoderm, and is required for thymus and parathyroid formation ([@R11]; [@R47]). *HOXA3* expression was also conserved between mouse and human; the anterior boundary of *HOXA3* expression in the week 6 (CS16-17) human embryo was the third PA and, as in the E10.5 mouse embryo, expression was observed throughout the third PP and surrounding mesenchyme ([Fig. 2B,B′](#F2){ref-type="fig"}).

In the mouse, both *Pax1* and *Pax9* are expressed in the foregut endoderm from E8.5 ([@R55]; [@R71]) and are then expressed in all four PPs and in the thymus throughout organogenesis, becoming restricted to subpopulations of TECs postnatally ([@R55]; [@R71]). Here, *PAX1* expression was investigated in a week 6 human embryo; expression was observed in all four PPs ([Fig. 2C,C′](#F2){ref-type="fig"}). *PAX9* expression was also examined in human embryos at week 6; expression was evident in the third and fourth PPs but was not detected in the first and second pouches ([Fig. 2D,D′](#F2){ref-type="fig"}). Thus, whereas the expression pattern of *PAX1* is conserved between mouse and human, *PAX9* expression in the human PE is more restricted than in the mouse at the equivalent developmental stage.

*Foxn1* is required cell-autonomously for development of mouse TECs but is not required for initiation of thymus organogenesis ([@R9]; [@R54]; [@R57]). Null mutations in *Foxn1* result in athymia and hairlessness in mice, rats and humans ([@R17]; [@R16]; [@R53]; [@R20]). In the mouse, *Foxn1* expression initiates at the ventral tip of the third PP at E11.25 (in CBAxC57BL/6 embryos) and spreads to the entire thymus domain by E11.5 ([@R23]). We could not detect *FOXN1* expression in the third PP of early week 6 (CS16) human embryos (not shown) but observed strong expression throughout the thymus domain of the third PP by mid-week 6 (CS16-17; [Fig. 2E](#F2){ref-type="fig"}), suggesting that timing of initiation of high-level *FOXN1* expression occurs at equivalent developmental stages in human and mouse. *FOXN1* expression was also seen throughout the thymic lobes at week 8 (CS20-21; [Fig. 2E′](#F2){ref-type="fig"}). The human thymus has been suggested to develop from both the third and fourth PPs ([@R56]; [@R69]). However, we did not detect *FOXN1* expression in the fourth PP at any stage of development ([Fig. 2E,E′](#F2){ref-type="fig"}). This establishes that in the human, as in the mouse, the thymus arises solely from the third PP, indicating that the mechanisms of early thymus organogenesis are closely conserved between these species. Of note is that *GCM2*, which delineates the parathyroid domain within the pouch, is expressed in both the third and fourth PPs in human ([@R43]), in keeping with the proposition that human parathyroids derive from both the third and fourth PPs.

We also determined the expression pattern of *P63* (*TP63* - Human Gene Nomenclature Database), because in the mouse p63 (Trp63 - Mouse Genome Informatics) has a pivotal role in many stratified epithelia, including the thymus ([@R10]; [@R64]). In the early week 6 (CS16-17) human embryo, *P63* was expressed by the ectoderm surrounding the pharyngeal arches ([Fig. 2F](#F2){ref-type="fig"}), consistent with its expression in the pharyngeal ectoderm in the mouse from E9.5 ([@R50]). By mid-week 6, *P63* expression was observed in the endoderm of the third PP ([Fig. 2F′](#F2){ref-type="fig"}) and by late week 8, it appeared to be expressed by all TECs ([Fig. 2F″](#F2){ref-type="fig"}). Thus, *P63* expression in the pharyngeal region is also conserved between mouse and human.

Finally, we analyzed the expression of *BMP2* and *BMP4*, because BMP signaling has been implicated both in thymus development ([@R25]) and as a possible regulator of *Foxn1* ([@R68]; [@R64]). *BMP4* expression was observed in the second and third PP endoderm and adjacent mesenchyme in the mid-week 6 (CS16-17) human embryo ([Fig. 2G,G′](#F2){ref-type="fig"}), consistent with its expression pattern at E10.5 in the mouse ([@R59]), whereas *BMP2* was expressed in the third and fourth PP endoderm of the early week 6 (CS16) embryo ([Fig. 2H](#F2){ref-type="fig"}), as observed in the mouse from E9.5 ([@R46]).

Collectively, these data demonstrate that the spatial and temporal expression of transcription factors and signaling molecules involved in mouse thymus organogenesis is highly conserved in human thymus development, albeit with some minor regional differences. This strongly suggests that the genetic mechanisms controlling thymus development are conserved between mouse and human. Our previous studies have shown that *Rhox4* and *Plet1* (1600029D21Rik - Mouse Genome Informatics), specific markers of the mouse third PP/early thymus primordium, are not expressed in this region during human thymus organogenesis ([@R52]; [@R13]). Thus, our data indicate that although the expression patterns of all genes implicated in thymus organogenesis by functional studies are conserved between mouse and human, not all gene expression patterns in this region are conserved between species.

Onset and progression of epithelial cell differentiation in the human thymic primordium {#S12}
---------------------------------------------------------------------------------------

We next investigated whether patterning of the human thymic primordium into cortical and medullary compartments occurred in a similar manner to in the mouse, and at what stage the onset of TEC differentiation occurred. In the adult mouse thymus, the structural proteins cytokeratin 8 (K8; Krt8 - Mouse Genome Informatics) and keratin 5 (K5; Krt5 - Mouse Genome Informatics) are broadly restricted to cortical TECs (cTECs) and medullary TECs (mTECs), respectively, and additionally are co-expressed by a minor TEC population found at the cortico-medullary junction and scattered throughout the cortex ([@R36]). These markers are also co-expressed by most TECs in the E11.5 mouse thymic primordium ([@R7]); by E12.5, high level K5 expression marks a medullary thymic epithelial progenitor cell population that also expresses high levels of claudin 4 (Cldn4) and, from ∼E13.5, co-stains with the mTEC marker lectin UEA1 ([@R28]).

At early week 7 (CS18), K5 and K8 were co-expressed by most, if not all, TECs in the human thymic primordium, consistent with the expression pattern seen at the equivalent stage (E11.5) in mouse ([Fig. 3A-A″](#F3){ref-type="fig"}). By mid-week 8 (CS21), these markers had begun to segregate such that, although most TEC expressed K8, K5 was more highly expressed by cells along the midline of the thymic lobe and in some scattered cells ([Fig. 3B-B″](#F3){ref-type="fig"}). Expression of EPCAM, a pan-epithelial marker in the mouse thymus that is expressed at higher levels in mouse mTECs than cTECs ([@R15]), was also similar in the mouse and human thymus. EPCAM was expressed by all TECs in the week 7 human thymic primordium ([Fig. 3C-C′](#F3){ref-type="fig"}) and by week 15 was expressed strongly by mTECs and weakly by cTECs ([Fig. 3D](#F3){ref-type="fig"}). These data suggested that the onset of overt TEC differentiation in human thymus development occurs around mid-week 8 (CS21), demonstrating that, as in mouse, human TEC development is initiated after the initiation of FOXN1 expression ([@R57]). Consistent with this conclusion, expression of a functional marker of TEC maturation, major histocompatibility complex (MHC) Class II (HLA-DR/DP/DQ), expression of which is Foxn1-dependent in the early mouse thymic priordium ([@R57]), was not detected in human TECs until mid-week 8 ([Fig. 3E-F″](#F3){ref-type="fig"}).

![**Onset of TEC differentiation in the human thymic primordium.** (**A-F**″) Immunohistochemical staining of thymic primordia at the developmental stages shown with anti-Keratin 5 (K5) and anti-Keratin 8 (K8) (A-B″), anti-EPCAM (C-D), or anti-HLA-DR/DP/DQ (MHC II) and anti-pan-Cytokeratin (PANK) (E-F″). Images are representative of at least two independent analyses. Wk, week. Scale bars: 150 μm in A-C,D-E″; 75 μm in C′,F-F″.](DEV087320F3){#F3}

We next determined the pattern of UEA1 staining in human thymus development, because in the mouse UEA1 binding identifies mTECs in the thymic primordium from E13.5 ([@R28]) and, subsequently, most postnatal mTECs ([@R15]). Surprisingly, as no UEA1 staining is observed at the equivalent stage in the mouse, UEA1 bound most, if not all, TECs within the week 7 human thymus ([Fig. 4A-A″](#F4){ref-type="fig"}). By mid-week 8, UEA1 staining on TEC was restricted to the central area of the thymic lobes ([Fig. 4B-B″](#F4){ref-type="fig"}), suggesting that medullary epithelial progenitor cells had arisen by mid-week 8, and a subpopulation of mTECs binding UEA1 at high intensity were present by week 15 of human fetal development ([Fig. 4D-D″](#F4){ref-type="fig"}). Of note is that some non-epithelial UEA1^+^ cells were also observed in the human fetal thymus, unlike in the mouse. These cells were initially seen lining week 8 thymic lobes ([Fig. 4B-B″](#F4){ref-type="fig"}) and were found throughout the thymus at week 10 and week 15, possibly indicating UEA1 staining of vasculature-associated cells ([Fig. 4C-D″](#F4){ref-type="fig"}).

![**Expression of markers of cortical and medullary TECs in human thymus development.** (**A-K**″) Medullary TEC differentiation. Images show staining with UEA1 (A-D″), anti-CLDN4 (E-G″), anti-CLDN4 and anti-HLA-DR/DP/DQ (MHC II) (H-H″) and anti-AIRE (I-K″). (**L-O**″) Cortical TEC differentiation. Images show staining with CD205 (L-M″) and CDR2 (N-O″). (**P-W**″) Chemokine expression. Images show staining with anti-CCL21 (P-Q″) and anti-CCL25 (R-W″). Developmental stages are as shown. Anti-pan-Cytokeratin (PANK) co-stain reveals the entire thymus primordium. Images are representative of at least two independent analyses. Wk, week. Scale bars: 150 μm in A-B″,D-F″,H-H″,N-W″; 75 μm in C-C″; 47.6 μm in G-G″; 50 μm in I-I″,L-M″; 55 μm in J-K″.](DEV087320F4){#F4}

We also investigated the expression of CLDN4, as the Cldn4^+^UEA1^+^ population in the fetal mouse thymus contains progenitors that give rise to Aire^+^ mTECs ([@R28]). By week 8, CLDN4 was expressed by TECs in the central area of the thymic lobes ([Fig. 2I](#F2){ref-type="fig"}; [Fig. 4E-G″](#F4){ref-type="fig"}). These CLDN4^+^ cells also expressed MHC class II (HLA-DR/DP/DQ; [Fig. 4H-H″](#F4){ref-type="fig"}), suggesting that, as in the mouse ([@R28]), these are the first cells to differentiate into mature medullary TECs. CLDN4 expression remained restricted to a subpopulation of mTECs and, by week 18, identified both small clusters of nucleated mTECs and swirls of cells surrounding an enucleated region that were strongly suggestive of Hassall's corpuscles ([Fig. 4G-G″](#F4){ref-type="fig"}).

The autoimmune regulator Aire is essential for induction of central tolerance in mice and humans ([@R49]) and therefore we analyzed AIRE expression during human thymus development. AIRE^+^ TECs were not present in the week 10 human thymic primordium (not shown), but were observed in medullary areas by week 13 ([Fig. 4I-I″](#F4){ref-type="fig"}) and had increased in number by week 17 ([Fig. 4J-K″](#F4){ref-type="fig"}).

To investigate differentiation towards the cTEC fate, we determined the expression pattern of CD205 (LY75 - Human Gene Nomenclature Database) ([@R65]) and CDR2 ([@R63]). CD205 has recently been shown to mark the onset of cTEC differentiation in the mouse and is expressed as early as E12.5 in mouse thymus development ([@R65]); later in fetal development, it may mark a common TEPC ([@R4]). CDR2 is restricted to cTECs in the human adult thymus ([@R63]). We were unable to detect CD205 or CDR2 expression in the early or mid-week 7 thymic primordium by immunohistochemistry ([Fig. 4L-L″,N-N″](#F4){ref-type="fig"}). However by mid-week 8, extensive expression of both markers was observed throughout the thymic lobes ([Fig. 4M-M″,O-O″](#F4){ref-type="fig"}). CDR2^+^ TECs within the mid-week 8 thymus did not express K5, suggesting that they may represent cortical sub-lineage-restricted epithelial progenitor cells. Again, these data are consistent with the onset of TEC differentiation occurring around mid-week 8 in the human thymic primordium.

The chemokine CCL21, which plays a role in hematopoietic colonization of the thymus in mice ([@R42]), was detected in scattered cells in the human thymic primordium at week 11 ([Fig. 4P-P″](#F4){ref-type="fig"}). The number of CCL21^+^ TECs was substantially increased by week 17 and appeared to be largely restricted to medullary regions ([Fig. 4Q-Q″](#F4){ref-type="fig"}), consistent with its localization in the mouse ([@R38]). CCL25, a chemokine expressed by mouse TECs in a Foxn1-dependent manner that also plays a role in hematopoietic colonization of the thymus ([@R42]; [@R57]), was first detected at mid-week 8 ([Fig. 4R-S″](#F4){ref-type="fig"}). CCL25 expression was initially detected in scattered cells throughout the human thymic primordium. By week 17, CCL25 expression was detected only in cortical TECs ([Fig. 4U-W″](#F4){ref-type="fig"}), as shown by co-staining with CDR2 and EPCAM ([Fig. 4V-W″](#F4){ref-type="fig"}), which mark cortical and medullary regions, respectively, by immunohistochemistry ([@R15]; [@R63]).

Immigration of mesenchymal cells and endothelial progenitors into the human thymic primordium {#S13}
---------------------------------------------------------------------------------------------

Neural crest-derived mesenchymal cells form the capsule and trabeculae of the fetal thymus and also generate the intrathymic pericytes ([@R18]). It is well established that thymic mesenchyme is at least partly responsible for regulating expansion ([@R2]; [@R35]; [@R1]) and migration ([@R26]; [@R19]) of the early thymic primordium. However, the timing of the initial immigration of mesenchymal cells into the human thymic primordium has not been determined. TE7 is a marker of human thymic mesenchymal cells that has been reported to stain the mesenchymal cells surrounding the thymic lobes at weeks 7 and 10, and to mark interlobular fibrous septae, vessels and thymic fibrous capsule at week 15 ([@R30]). At early week 7, we observed cells stained with TE7 surrounding the thymic primordium, but no stained cells were seen within the thymic epithelium ([Fig. 5A,A′](#F5){ref-type="fig"}). By mid-week 7, formation of trabeculae was apparent and TE7 expression was also seen in the anterior end of the thymic/parathyroid primordium, where it appeared to be in the luminal spaces ([Fig. 5B,B′](#F5){ref-type="fig"}). However, mesenchymal cells were not evident within the thymic epithelium region itself until mid-week 8 ([Fig. 5C,C′](#F5){ref-type="fig"}). At subsequent stages, TE7^+^ thymic mesenchyme divided the thymus into discrete lobules, and TE7^+^ cells were also present throughout the epithelial regions ([Fig. 5D-E′](#F5){ref-type="fig"}) ([@R30]). Thus, the timing of onset of migration of mesenchymal cells into the human thymic primordium closely follows the onset of FOXN1 expression ([Fig. 2E](#F2){ref-type="fig"}), consistent with the timing of this event in the mouse ([@R18]).

![**Colonization of the human thymic primordium by mesenchymal cells.** (**A-E**′) Images show staining with TE7 at the developmental stages shown. Anti-pan-Cytokeratin (PANK) reveals the entire thymus primordium. Images are representative of at least two independent analyses. Wk, week. Scale bars: 150 μm in A-B′,D-E′; 75 μm in C,C′.](DEV087320F5){#F5}

Immigration of vascular progenitors into the mouse thymus is closely linked to that of neural crest-derived cells, and both of these processes are Foxn1 dependent ([@R51]; [@R57]). However, again, the timing of vascular endothelial progenitor entry into the human thymus has not been determined. Our analysis identified the presence of CD34^hi^CD31^+^ cells in the connective tissue between the carotid artery and the thymus primordium at mid-week 7 ([Fig. 6A-C″](#F6){ref-type="fig"}); occasional cells at this stage were found within the epithelial component of the primordium ([Fig. 6D-D″](#F6){ref-type="fig"}). By late week 7 to mid-week 8, CD34^hi^ cells were found within the thymic lobes ([Fig. 6E-F″](#F6){ref-type="fig"}) and all co-expressed both CD31 (PECAM1 - Human Gene Nomenclature Database) and VE cadherin (CDH5 - Human Gene Nomenclature Database), identifying them as endothelial progenitors ([Fig. 6G-G″](#F6){ref-type="fig"}). Of note is that the CD34^hi^ cells present within the thymic primordium at late week 7 to early week 8 did not express CD45 (PTPRC - Human Gene Nomenclature Database) ([Fig. 6E-E″](#F6){ref-type="fig"}). Blood vessels per se were present by mid-week 9 (note long blood vessel-like structures at mid-week 9) ([Fig. 6H-I″](#F6){ref-type="fig"}).

![**Colonization of the human thymic primordium by vascular endothelial cells.** (**A-I**″) Images show staining with anti-CD34 at the developmental stages shown. Anti-pan-Cytokeratin (PANK) reveals the entire thymus primordium. Anti-CD45 reveals hematopoietic cells. CD31 (G-I″) and VE cadherin (VEcad; I-I″) staining reveal vascular endothelial cells. DAPI reveals nuclei. White arrowheads in A-F″ indicate vascular endothelial cells. Images are representative of at least two independent analyses. C, carotid artery; Th, thymus; CS, Carnegie stage. Scale bars: 75 μm.](DEV087320F6){#F6}

Some variation in timing of colonization with endothelial progenitors was observed: in the thymus primordium from a CS19 fetus (mid to late week 7; 48-51 days old) and a CS20 fetus (late week 7 to early week 8), several CD34^hi^ cells were present within the epithelial compartment, and were localized to one discrete region ([Fig. 6D-E″](#F6){ref-type="fig"}). However, in a CS21 fetus (mid to late week 8; 53-54 days old) CD34^hi^ cells were present in the mesenchymal capsule but were not detected within the epithelial component of the thymus ([Fig. 6F-F″](#F6){ref-type="fig"}). These differences in kinetics of colonization between different fetal thymi are likely to reflect the effects of genetic variation within the human population on fetal thymus development; in this context, it is well established that thymus organogenesis proceeds at different rates in different inbred mouse strains.

CD45^+^CD7^+^ T-lineage progenitors are first present at week 8 and lack high level CD34 expression {#S14}
---------------------------------------------------------------------------------------------------

Hematopoietic colonization of the human fetal thymus has previously been proposed to occur during early week 8, and the week 7 human primordium was reported as being devoid of hematopoietic cells ([@R29]). However, as acknowledged by the authors, this study was compromised by the limited material available ([@R29]) and, thus, although the timing at which subsequent stages in T-cell development are first observed has been determined ([@R61]), the stage at which the earliest hematopoietic cells colonize the human thymus remains unknown. We therefore sought to determine the kinetics of hematopoietic colonization of the human thymus using markers associated with human hematopoietic progenitor cells, including early T-lineage precursors. Of note is that the earliest T-lineage restricted precursors in human are thought to be bone marrow-derived CD45^+^CD34^hi^CD7^+^ cells based on functional analysis of hematopoietic cells at week 8-9 of fetal development, the earliest time-point examined ([@R27]).

We observed CD45^+^ hematopoietic cells in the perithymic space at early week 7 ([Fig. 7A,A′](#F7){ref-type="fig"}), and by early to mid-week 7 we detected occasional CD45^+^ cells within the thymic primordium of some embryos ([Fig. 7B,B′](#F7){ref-type="fig"}, green arrow). By early to mid-week 8, CD45^+^ cells lined the perithymic space and were also distributed throughout the thymic lobes, and by week 10 the numbers of CD45^+^ cells within the thymus had increased dramatically ([Fig. 7C,D](#F7){ref-type="fig"}). However, no CD34^hi^CD45^+^ cells could be detected prior to week 9 ([Fig. 7E-M″](#F7){ref-type="fig"}). Co-staining with additional markers indicated that at mid-week 8 a proportion of the CD45^+^ cells were Mac1 (IGTAM)^+^ macrophages ([Fig. 7F-F″′](#F7){ref-type="fig"}). Of note is that comparison of immunohistochemistry and flow cytometric staining data indicated that only cells expressing high levels of CD34 were detected by immunohistochemistry.

![**Colonization of the human thymic primordium by hematopoietic cells.** (**A-M**″) Images show staining of microdissected human thymic primordia with anti-CD45, anti-CD34, anti-CD7 and Mac1 as indicated, at the developmental stages shown. Anti-pan-Cytokeratin (PANK) reveals the entire thymus primordium. Green arrow in B indicates CD45^+^ cell within the thymic epithelial compartment; white arrows indicate CD45^+^ cells present in the perithymic mesenchyme. C′,C″ show detail from boxed regions on mid-week 8 image (C′). I-I″ show boxed area from H-H″. Images are representative of at least two independent analyses. Scale bars: 75 μm in K-M″; 150 μm in D. (**N-V**) Flow cytometric analysis of human thymic primordia at the developmental stages shown. (N-U) Plots show staining with anti-CD45 and anti-CD34 and anti-CD7 after gating on live cells (i.e. against DAPI). Q,S,U show cells after gating on CD45^+^ cells (P,R,T). Boxes on O,Q,S,U at each age indicate CD34^hi^, CD34^int^ and CD34^lo/neg^ cells. (N-U) *n*=1 for each age shown. (V) Plot shows staining with markers for plasmacytoid (CD123^+^BDCA2^+^) dendritic cells after gating on CD45^+^CD19^-^CD3^-^ cells and is representative of at least two independent analyses. SSC, side scatter; Wk, week. See also [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.087320/-/DC1) Table S2.](DEV087320F7){#F7}

Surprisingly, given the absence of CD34^hi^CD45^+^ cells at this stage, CD45^+^CD7^+^ cells were observed within the thymic lobes from early week 8, when they comprised a minor subpopulation of intrathymic CD45^+^ cells ([Fig. 7G-I″](#F7){ref-type="fig"}; CD45^+^CD7^+^Mac1^-^; CD45^+^CD7^-^Mac1^+^ and CD45^+^CD7^-^Mac1^-^ cells were all present at this stage). Consistent with previous reports that CD7 identifies extra-thymic hematopoietic precursor cells with T-lineage potential ([@R29]; [@R31]), we observed some CD7^int^ cells located in the perithymic space. These cells were sometimes juxtaposed to CD7^hi^ cells that appeared to be actively entering the thymus, suggesting that CD7 upregulation might occur upon migration into the thymic epithelium ([Fig. 7H-I″](#F7){ref-type="fig"}). However, intrathymic CD34^hi^CD7^hi^ cells were not detected until mid-week 9, when they were observed closely associated with the blood vessels ([Fig. 7K-U](#F7){ref-type="fig"}). Most intra-thymic CD7^+^ cells at early week 8 were CD34^int^, consistent with the presence of CD34^int^ cells in the fetal liver (FL) ([Fig. 7P,Q](#F7){ref-type="fig"}). A minor population of CD34^lo/neg^CD7^+^ cells were also present at week 8, which might represent the CD34^neg^CD7^+^CD56^+^ natural killer (NK) cell population previously described in the FL ([@R60]; [@R6]). However, the week 8 hematopoietic population contained T-cell precursors, as culture of week 8 thymic lobes microdissected free of any other tissues resulted in a robust expansion of CD45^+^ thymocytes ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.087320/-/DC1) Fig. S1). Furthermore, expression of c-Kit (*KIT* - Human Gene Nomenclature Database), *IL7R*, pre Tα (*PTCRA* - Human Gene Nomenclature Database), *RAG1*, CD3δ (*CD3D* - Human Gene Nomenclature Database), and TCR β and γ (*TRB* and *TRG* - Human Gene Nomenclature Database) constant region mRNA was detected in microarray analysis of whole mid-week 8 fetal human thymic lobes ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.087320/-/DC1) Table S2). Collectively, these data pinpoint the stage of human thymus development at which colonization by hematopoietic progenitors occurs, and identify a novel subpopulation of CD34^int^CD7^+^ cells that might represent intrathymic T lineage-restricted progenitors.

Subsequent analyses confirmed previous studies indicating the appearance of CD4 and CD8 single positive and γδ TCR^+^ thymocytes, and CD4^+^CD25^+^ T regulatory cells in the human fetal thymus by week 15 ([@R44]; [@R21]; [@R29]; [@R12]) (data not shown). Low numbers of conventional dendritic cells (cDCs) were detected at week 15, consistent with a previous report indicating their presence at week 12 ([@R34]). CD11c^+^CD11b^+^ cDCs increased proportionally by week 16 (not shown), together with a numerical increase in the entire cDC population. Of note is that plasmacytoid dendritic cells were already evident at week 15 ([Fig. 7V](#F7){ref-type="fig"}).

DISCUSSION {#S15}
==========

The data presented above address the current profound gap in understanding of human thymus development. Collectively, they demonstrate that the principal genetic mechanisms currently known to regulate thymus organogenesis in the mouse are conserved in humans, and that key cellular processes, including the developmental origin of the thymus in the third pharyngeal pouches, are also conserved. They establish that overt differentiation of cortical and medullary TECs occurs from mid-week 8 in the human thymic primordium and closely mirrors the progression seen in mouse in terms of phenotypic and functional marker expression, and that colonization of the human thymic primordium by endothelial and mesenchymal cells occurs from early and mid-week 8, respectively. Finally, they define the timing of onset of hematopoietic cell colonization of the human thymic primordium and reveal, in contrast to expectations from previous studies, that the first colonizing hematopoietic cells that express T lineage affiliated markers are CD45^+^CD7^+^CD34^int^ cells, which are present from early week 8. These findings are summarized in [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.087320/-/DC1) Table S3.

Conservation of mechanisms of thymus organogenesis between mouse and human {#S16}
--------------------------------------------------------------------------

The mouse is the principal model organism used to determine regulatory mechanisms operating to control thymus development and function, and therefore interrogation of its utility for predicting mechanisms that control these processes in the human is essential. The data presented above establish that the spatial and temporal expression pattern of all of the genes tested, which have been demonstrated by genetic analyses to have functional roles in thymus development, are conserved between mouse and human. They therefore validate the mouse as a model for understanding human thymus organogenesis. Of note is that although some variation in expression between mouse and human was observed in the genes analyzed herein, this did not affect expression in the thymus domain; for instance, *PAX9* is expressed throughout the pharyngeal pouches in mouse but was detected only in pouches 3 and 4 in human. However, it is of interest that two genes, *RHOX4* and *PLET1*, expression of which in mouse is restricted to the pharyngeal endoderm and the thymus domain of the third pharyngeal pouch, respectively, at this developmental stage, are not expressed in the human pharyngeal pouches or thymic rudiment, indicating that not all gene expression patterns are conserved. In this regard, we note that neither of these genes has been shown to be important for thymus organogenesis by functional studies and, indeed, both are currently of unknown function.

Differentiation of the earliest progenitor cells in the human thymic primordium {#S17}
-------------------------------------------------------------------------------

The data presented above demonstrate that overt differentiation of cortical and medullary TEC occurs at around mid-week 8. However, the thymic rudiment itself is present from early week 6 and therefore, our data further indicate that the week 6 and week 7 thymic primordia consist mainly of undifferentiated TECs. Thus, cell surface markers expressed by most TECs at these developmental stages will be useful for isolating and characterizing the differentiative potential of early progenitor TECs. Similarly, the expression patterns demonstrated here for CD205 and CLDN4 are consistent with these markers identifying early medullary and cortical sub-lineage-restricted progenitors in the human, as well as mouse, thymus. Collectively, these data pave the way for prospective isolation and functional testing of defined human fetal TEC subpopulations, which will be essential if progress is to be made in defining conditions for *in vitro* propagation of human TEPCs or for generating these cells from embryonic stem cells for use in cell replacement therapies.

We note that FOXN1, a master regulator of TEC differentiation, is expressed in the human thymic primordia from mid-week 6. In the mouse, high-level Foxn1 expression is initiated at E11.5 and the onset of overt TEC differentiation closely follows this upregulation. The interval between upregulation of FOXN1 and the appearance of differentiating cTECs and mTECs is therefore much longer in human than in mouse. This probably reflects differences in cell cycle; however, it is also possible that other, as yet unknown mechanisms, limiting the time of onset of TEC differentiation are initiated or repressed with different kinetics to FOXN1 in the human.

Kinetics of initial mesenchymal and vascular endothelial cell entry into the human thymus {#S18}
-----------------------------------------------------------------------------------------

Our data indicate that entry of vascular endothelial progenitor cells into the human thymus occurs as early to mid-week 8, with migrating cells observed in the connective tissue between the carotid artery and the thymus from early to mid-week 7. They further show that, although formation of trabeculae is observed from mid-week 7, the time of entry of neural crest-derived mesenchymal cells into the epithelial regions of the thymus is mid-week 8. These processes are thus closely linked, as in the mouse. Notably, both events occur after initiation of high-level FOXN1 expression in the human thymus, consistent with the demonstration in mouse that thymic colonization with both mesenchymal and vascular endothelial cells is Foxn1 dependent. However, our data further suggest that entry of vascular endothelial progenitors into the epithelial region of the thymic primordium precedes its colonization with mesenchymal cells, in contrast to the widespread assumption that immigration of vascular endothelial cells follows that of neural crest-derived mesenchyme.

Identity of the first thymus-seeding hematopoietic cells {#S19}
--------------------------------------------------------

The data presented in [Fig. 7](#F7){ref-type="fig"} establish that hematopoietic cell colonization of the human thymus primordium occurs from early to mid-week 7. As in mouse, hematopoietic colonization of the thymus therefore closely follows upregulation of high level FOXN1 expression, consistent with FOXN1-regulation of CCL25 and DLL4, which are required for migration and T lineage commitment of thymus seeding progenitors, respectively ([@R42]; [@R32]; [@R37]).

The earliest human thymus seeding T lineage-restricted progenitors have previously been proposed to be CD45^+^CD34^hi^CD7^+^ cells, based on functional analysis of hematopoietic cells in the week 8-9 fetal thymus ([@R21]; [@R29]; [@R27]). Our data indicate that the hematopoietic population of the early human fetal thymus is heterogeneous, and that all intrathymic hematopoietic cells are CD34^int/-^ until early to mid-week 9. Indeed, the first colonizing hematopoietic cells appearing at early week 7 are CD45^+^CD34^-^CD7^-^, and some CD45^+^ at least as early as early week 8 are Mac1^+^ macrophages. Intrathymic CD45^+^CD34^int^CD7^+^ and CD45^+^CD34^lo/-^CD7^+^ cells are present from early week 8; this was surprising, because the earliest intrathymic T-lineage progenitors were expected to express CD34 ([@R21]; [@R29]; [@R27]). Although we cannot exclude the possibility that these cells mature within the thymic primordium to generate CD45^+^CD34^hi^CD7^+^ cells, we note that CD45^+^CD34^hi^CD7^+^ cells first appear within the thymus at mid-week 9 coincident with establishment of blood vessels, and furthermore that cells of this phenotype are initially found closely associated with blood vessels. However, the thymus contains T-lineage progenitors at least as early as week 8, as evidenced by the robust development of thymocytes in fetal thymic organ cultures established at this developmental stage and the intrathymic expression of genes associated with early human thymocyte development. Thus, we favor the idea that the thymus-seeding population changes once the vasculature has been established as the primary route of entry, and comprises CD45^+^CD34^hi^CD7^+^ cells only after this point.

CD45^+^CD34^lo/-^CD7^+^ cells have been described previously in the FL; these are NK cells, and also express CD56 (NCAM1 - Human Gene Nomenclature Database) ([@R60]; [@R6]). Thus, the minor CD45^+^CD34^lo/-^CD7^+^ population present at week 8 might also be NK cells. The CD45^+^CD34^int^CD7^+^ population present in the pre-vascular thymus is, however, a novel intrathymic hematopoietic population that is probably T lineage committed based on its expression of CD7. In this regard, it is of interest that CD7^hi^ cells were never detected in the connective tissue associated with the pre-vascular thymus or in the perithymic space, but were sometimes observed interspersed with thymic epithelial cells adjacent to the mesenchymal capsule, suggesting that in the pre-vascular thymus, upregulation of CD7 might occur upon contact with thymic epithelial cells. Of note is that the FL contains a population of CD45^+^CD34^int^ CD7^-^ cells ([@R27]) that might constitute precursors for this population. Based on these data, we therefore suggest that the pre-vascular thymus is initially seeded by CD45^+^CD34^int^CD7^-^ cells and that upregulation of CD7 in these cells occurs dynamically as part of the thymus-seeding process. We further suggest that this population is superseded by the previously described T lineage-restricted CD45^+^CD34^hi^CD7^+^ population ([@R27]) only following establishment of the thymic vasculature.
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